One of the most prestigious magazines, Time Magazine, revealed the list of the Most Influential People of 2025, and surprisingly, no Indian was featured in the list this year.
The 2025 TIME100 is here: TIME’s annual list of the world’s most influential people https://t.co/O1HtHYtj1o
— TIME (@TIME) April 16, 2025
In 2024, Bollywood actor Alia Bhatt and Olympian wrestler Sakshi Malik were among the few Indians who featured on the list.
The magazine’s annual list is divided into several categories, including ‘Leaders’, ‘Icons’, and ‘Titans’.
Among the world leaders and political heavyweights included on this year’s list are US President Donald Trump, Elon Musk and Mexican presidential front-runner Claudia Sheinbaum.
Other global power players included JD Vance, Robert F. Kennedy Jr., Keir Starmer, Javier Milei, Tedros Adhanom Ghebreyesus and Friedrich Merz.
Who Were On TIME’s Most Influential Cover?
The 2025 issue is released with five international covers, each spotlighting a standout honoree :
- Demi Moore, acclaimed actor and producer
- Snoop Dogg, legendary artist and entrepreneur
- Serena Williams, former tennis champion turned business mogul
- Ed Sheeran, global music phenomenon
- Demis Hassabis, co-founder and CEO of Google DeepMind, the AI powerhouse, is reshaping tech frontiersThe ‘Leaders’ list, however, does include Reshma Kewalramani this year, the CEO of Vertex Pharmaceuticals of Indian origin. She immigrated from India at age 11 and became the first woman CEO of a large, public US biotechnology company.
Time’s profile of Reshma Kewalramani, written by author Jason Kelly, said, “Reshma sat on my board at Ginkgo Bioworks, and her insights proved invaluable: she knows how to effectively push the limits of science while navigating the drug-approval process. She told us that when you are doing something innovative, if it sounds crazy or impossible, that’s OK—it’s only because no one has done it before.”
“Under her leadership, Vertex secured the first-ever FDA approval for a CRISPR-based therapy, which treats sickle cell disease by correcting patients’ own DNA mutations. Our bodies speak the language of DNA. Our best drugs in the future will use DNA to talk directly back to our bodies, leading to many more cures. Reshma is the kind of leader who can deliver that extraordinary future—it only seems crazy because no one’s done it before,” Jason Kelly further wrote.
